Table of Contents
ISRN Oncology
Volume 2011 (2011), Article ID 405656, 7 pages
http://dx.doi.org/10.5402/2011/405656
Research Article

Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers

1N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Kashirskoe Shosse, 24, Moscow 115478, Russia
2Chemical Diversity Research Institute, Rabochaya Street 2a, Khimki, Moscow 141401, Russia
3N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences, Leninsky Prospect 47, Moscow 119991, Russia
4Family Medicine Area, ASL1 Legnano and “Metabloc Cancer Center, ” c/o Centro Medico Kines, Castano Primo, 20022 Milan, Italy

Received 3 May 2011; Accepted 17 June 2011

Academic Editor: T.-C. Hour

Copyright © 2011 Natalia Yu. Anisimova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Natalia Yu. Anisimova, Andrey V. Sosnov, Nadezhda E. Ustyuzhanina, Gianfranco Baronzio, and Mikhail V. Kiselevsky, “Cytotoxic Activity of Peripheral Blood Mononuclear Leukocytes, Activated by Interleukin-2/β-Cyclodextrin Nanocomposition against Androgen Receptor-Negative Prostate Cancers,” ISRN Oncology, vol. 2011, Article ID 405656, 7 pages, 2011. doi:10.5402/2011/405656